UBS O'Connor’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,899
| Closed | -$194K | – | 273 |
|
|
2024
Q4 | $194K | Buy |
26,899
+4,851
| +22% | +$35K | 0.01% | 311 |
|
|
2024
Q3 | $135K | Sell |
22,048
-17,952
| -45% | -$110K | ﹤0.01% | 369 |
|
|
2024
Q2 | $266K | Sell |
40,000
-16,795
| -30% | -$112K | 0.01% | 384 |
|
|
2024
Q1 | $578K | Buy |
56,795
+22,497
| +66% | +$229K | 0.02% | 317 |
|
|
2023
Q4 | $386K | Buy |
+34,298
| New | +$386K | 0.01% | 363 |
|